Iovance Biotherapeutics (IOVA) Competitors $8.18 -0.41 (-4.77%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends IOVA vs. TWST, RLAY, CBPO, FATE, NKTR, SRPT, CTLT, RVMD, QGEN, and ITCIShould you be buying Iovance Biotherapeutics stock or one of its competitors? The main competitors of Iovance Biotherapeutics include Twist Bioscience (TWST), Relay Therapeutics (RLAY), China Biologic Products (CBPO), Fate Therapeutics (FATE), Nektar Therapeutics (NKTR), Sarepta Therapeutics (SRPT), Catalent (CTLT), Revolution Medicines (RVMD), Qiagen (QGEN), and Intra-Cellular Therapies (ITCI). These companies are all part of the "medical" sector. Iovance Biotherapeutics vs. Twist Bioscience Relay Therapeutics China Biologic Products Fate Therapeutics Nektar Therapeutics Sarepta Therapeutics Catalent Revolution Medicines Qiagen Intra-Cellular Therapies Twist Bioscience (NASDAQ:TWST) and Iovance Biotherapeutics (NASDAQ:IOVA) are both mid-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, community ranking, analyst recommendations, institutional ownership, media sentiment, risk and valuation. Do analysts recommend TWST or IOVA? Twist Bioscience presently has a consensus price target of $51.22, suggesting a potential upside of 38.85%. Iovance Biotherapeutics has a consensus price target of $22.33, suggesting a potential upside of 173.02%. Given Iovance Biotherapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Iovance Biotherapeutics is more favorable than Twist Bioscience.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Twist Bioscience 1 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.67Iovance Biotherapeutics 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.89 Does the MarketBeat Community favor TWST or IOVA? Iovance Biotherapeutics received 469 more outperform votes than Twist Bioscience when rated by MarketBeat users. Likewise, 74.44% of users gave Iovance Biotherapeutics an outperform vote while only 57.83% of users gave Twist Bioscience an outperform vote. CompanyUnderperformOutperformTwist BioscienceOutperform Votes9657.83% Underperform Votes7042.17% Iovance BiotherapeuticsOutperform Votes56574.44% Underperform Votes19425.56% Does the media prefer TWST or IOVA? In the previous week, Iovance Biotherapeutics had 5 more articles in the media than Twist Bioscience. MarketBeat recorded 17 mentions for Iovance Biotherapeutics and 12 mentions for Twist Bioscience. Iovance Biotherapeutics' average media sentiment score of 0.66 beat Twist Bioscience's score of 0.15 indicating that Iovance Biotherapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Twist Bioscience 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Iovance Biotherapeutics 7 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders hold more shares of TWST or IOVA? 77.0% of Iovance Biotherapeutics shares are owned by institutional investors. 3.9% of Twist Bioscience shares are owned by insiders. Comparatively, 12.1% of Iovance Biotherapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has higher valuation & earnings, TWST or IOVA? Twist Bioscience has higher revenue and earnings than Iovance Biotherapeutics. Twist Bioscience is trading at a lower price-to-earnings ratio than Iovance Biotherapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTwist Bioscience$245.11M8.82-$204.62M-$3.82-9.66Iovance Biotherapeutics$1.19M2,095.04-$444.04M-$1.49-5.49 Which has more risk and volatility, TWST or IOVA? Twist Bioscience has a beta of 1.78, indicating that its share price is 78% more volatile than the S&P 500. Comparatively, Iovance Biotherapeutics has a beta of 0.6, indicating that its share price is 40% less volatile than the S&P 500. Is TWST or IOVA more profitable? Twist Bioscience has a net margin of -74.63% compared to Iovance Biotherapeutics' net margin of -451.25%. Twist Bioscience's return on equity of -32.17% beat Iovance Biotherapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Twist Bioscience-74.63% -32.17% -25.55% Iovance Biotherapeutics -451.25%-58.43%-45.48% SummaryIovance Biotherapeutics beats Twist Bioscience on 12 of the 18 factors compared between the two stocks. Ad WealthPressThe only candlestick pattern worth a darnIt’s widely known that 80% of daily market action is driven by Wall Street algorithms… Now, most people think of the algorithms are “bad” When in reality, they are neither good nor bad… They are simply programmed to buy and sell certain stocks over and over again… But here is the thing… They are predictable… They typically buy the same stocks at the same levels over and over again…Follow this link here and enter your email address to sign up… Get Iovance Biotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for IOVA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IOVA vs. The Competition Export to ExcelMetricIovance BiotherapeuticsBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.49B$2.94B$5.12B$8.72BDividend YieldN/A1.81%5.18%4.07%P/E Ratio-5.4920.4872.8114.16Price / Sales2,095.04224.491,250.2081.71Price / CashN/A176.6640.7036.03Price / Book3.224.056.455.94Net Income-$444.04M-$42.42M$119.73M$225.73M7 Day Performance-22.72%-10.63%-5.13%-1.34%1 Month Performance-19.57%-5.81%-2.71%1.15%1 Year Performance61.98%24.19%31.08%24.02% Iovance Biotherapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IOVAIovance Biotherapeutics4.2756 of 5 stars$8.18-4.8%$22.33+173.0%+85.9%$2.49B$1.19M-5.49500Insider SellingHigh Trading VolumeTWSTTwist Bioscience3.6571 of 5 stars$42.49-6.1%N/A+93.4%$2.49B$245.11M-11.12990Upcoming EarningsInsider SellingNews CoverageRLAYRelay Therapeutics3.4835 of 5 stars$5.81-2.2%N/A-36.7%$777.90M$25.55M-2.23304CBPOChina Biologic ProductsN/A$119.99+1.7%N/A+0.0%$4.72B$503.70M33.522,269FATEFate Therapeutics4.1486 of 5 stars$2.17-8.8%N/A-15.1%$247.12M$63.53M-1.32550Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageNKTRNektar Therapeutics4.2039 of 5 stars$1.28-2.3%N/A+112.0%$236.11M$90.12M-1.52220SRPTSarepta Therapeutics4.9455 of 5 stars$112.48-1.6%N/A+26.0%$10.74B$1.24B89.981,314Analyst UpgradeCTLTCatalent2.8783 of 5 stars$59.15-0.2%N/A+48.7%$10.74B$4.42B-26.1716,900Analyst UpgradeInsider SellingNews CoverageRVMDRevolution Medicines3.5596 of 5 stars$58.13-2.0%N/A+159.4%$9.78B$11.58M-16.19443QGENQiagen4.2892 of 5 stars$42.63-1.4%N/A+1.6%$9.73B$1.97B109.315,967Analyst RevisionITCIIntra-Cellular Therapies4.5093 of 5 stars$88.22-0.3%N/A+51.6%$9.35B$464.37M-101.40560Insider SellingPositive News Related Companies and Tools Related Companies Twist Bioscience Competitors Relay Therapeutics Competitors China Biologic Products Competitors Fate Therapeutics Competitors Nektar Therapeutics Competitors Sarepta Therapeutics Competitors Catalent Competitors Revolution Medicines Competitors Qiagen Competitors Intra-Cellular Therapies Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:IOVA) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Iovance Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Iovance Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IOVA Stock Alerts